By Christy Santhosh Dec 2 (Reuters) - The U.S. Food and Drug Administration's drug evaluation chief, Richard Pazdur, is set ...

Dec 2 (Reuters) - The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard ...

Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...

Dec 2 (Reuters) - The U.S. Food and Drug Administration on Tuesday issued new draft guidance on reducing the use of lab ...

Richard Pazdur, the US Food and Drug Administration’s lead drug regulator, plans to retire from the agency only weeks after ...

Several news outlets, including Politico, CNN and the Washington Post, reported on December 2 that Food and Drug ...

The top drug regulator at the Food and Drug Administration, Richard Pazdur, has decided to retire from the agency just three ...

FDA has determined that NRx’s Abbreviated New Drug Application (ANDA) is “substantially complete” and received for review.

Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...

By Sriparna Roy (Reuters) -The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially life-threatening kidney disease, the health regulator's ...

ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology ...

Food and Drug Administration'‌s newly appointed head of the drug evaluation ‌department, Richard Pazdur, is set to retire ...